Pfizer (PFE) News Today $26.36 +0.59 (+2.29%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Stock Traders Purchase Large Volume of Call Options on Pfizer (NYSE:PFE)December 22 at 1:27 AM | americanbankingnews.comMarket Today: Qualcomm's Legal Victory and Pfizer's FDA Approval Highlight Key DevelopmentsDecember 21 at 4:31 PM | gurufocus.comPfizer Inc. (PFE) Is Among the Best Dividend Leaders to Buy According to Wall Street AnalystsDecember 21 at 11:38 AM | insidermonkey.comMy Top 10 Stocks to Buy for 2025December 21 at 4:05 AM | fool.comLeerink Partnrs Weighs in on Pfizer's Q3 Earnings (NYSE:PFE)December 21 at 2:25 AM | americanbankingnews.comPfizer gets FDA accelerated approval for BraftoviDecember 20 at 5:44 PM | seekingalpha.comInvestors Purchase High Volume of Call Options on Pfizer (NYSE:PFE)Pfizer Inc. (NYSE:PFE - Get Free Report) saw some unusual options trading activity on Friday. Stock investors bought 201,090 call options on the stock. This is an increase of approximately 28% compared to the typical volume of 157,196 call options.December 20 at 4:17 PM | marketbeat.comPfizer announces FDA approval of Braftovi combinationDecember 20 at 2:45 PM | tipranks.comU.S. FDA Approves Pfizer's BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal CancerDecember 20 at 2:03 PM | businesswire.comPfizer (NYSE:PFE) Trading Up 1.6% - What's Next?Pfizer (NYSE:PFE) Trading Up 1.6% - Still a Buy?December 20 at 1:29 PM | marketbeat.comPharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A DealsDecember 20 at 12:37 PM | msn.comIs Pfizer (PFE) a Cheap NYSE Stock to Invest in Now?December 20 at 12:37 PM | msn.comLeerink Partnrs Estimates Pfizer's Q3 Earnings (NYSE:PFE)Pfizer Inc. (NYSE:PFE - Free Report) - Equities research analysts at Leerink Partnrs lifted their Q3 2025 earnings per share (EPS) estimates for shares of Pfizer in a report issued on Wednesday, December 18th. Leerink Partnrs analyst D. Risinger now anticipates that the biopharmaceutical companyDecember 20 at 7:04 AM | marketbeat.comPrincipal Financial Group Inc. Decreases Stake in Pfizer Inc. (NYSE:PFE)Principal Financial Group Inc. cut its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 12.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,088,319 shares of the biopharmaceutical company's stockDecember 20 at 5:16 AM | marketbeat.comPfizer (NYSE:PFE) Trading 0.4% Higher - Time to Buy?Pfizer (NYSE:PFE) Trading 0.4% Higher - What's Next?December 19 at 1:47 PM | marketbeat.comPfizer price target raised to $28 from $27 at Wells FargoDecember 19 at 1:01 PM | markets.businessinsider.comPfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with AnalystsDecember 19 at 10:00 AM | businesswire.comPfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?December 19 at 6:07 AM | fool.comPfizer (NYSE:PFE) Shares Down 0.4% After Analyst DowngradeDecember 19 at 1:31 AM | americanbankingnews.comTruist Financial Gives a Buy Rating to Pfizer (PFE)December 18, 2024 | markets.businessinsider.comPfizer price target lowered to $32 from $36 at TruistDecember 18, 2024 | markets.businessinsider.comJim Cramer’s Take on Pfizer (PFE): Can CEO Dr. Bourla’s Bold Strategy Overcome Debt and Turn the Stock Around?December 18, 2024 | insidermonkey.comPfizer Momentum Shift Makes Me Less Bullish (Technical Analysis)December 18, 2024 | seekingalpha.comPfizer (NYSE:PFE) Shares Down 0.4% Following Analyst DowngradePfizer (NYSE:PFE) Trading Down 0.4% Following Analyst DowngradeDecember 18, 2024 | marketbeat.comHot or Not, Stock Market Edition: 12/19/2024December 18, 2024 | wallstreetzen.comTruist Financial Issues Pessimistic Forecast for Pfizer (NYSE:PFE) Stock PriceTruist Financial dropped their price objective on shares of Pfizer from $36.00 to $32.00 and set a "buy" rating for the company in a report on Wednesday.December 18, 2024 | marketbeat.comIs Pfizer Stock Undervalued?December 18, 2024 | forbes.comPfizer (NYSE:PFE) Issues FY 2024 Earnings GuidancePfizer (NYSE:PFE) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.750-2.950 for the period, compared to the consensus estimate of 2.930. The company also issued revenue guidance of $61.0 billionillion-$64.0 billionillion, compared to the consensus estimate of $62.9 billionillion.December 18, 2024 | marketbeat.com3 of the Safest Ultra-High-Yield Dividend Stocks to Buy in 2025December 18, 2024 | fool.comPfizer’s Balanced Outlook: Hold Rating Amid Uncertainties and Growth PotentialDecember 18, 2024 | markets.businessinsider.comPfizer’s Stable Outlook Amid Growth Challenges and Policy Risks Leads to Hold RatingDecember 18, 2024 | markets.businessinsider.comUBS Sticks to Its Hold Rating for Pfizer (PFE)December 17, 2024 | markets.businessinsider.comPfizer's 2025 Outlook: Is This the Breakthrough Investors Have Been Waiting For?December 17, 2024 | finance.yahoo.comPfizer (NYSE:PFE) Trading Up 4% - Here's What HappenedPfizer (NYSE:PFE) Stock Price Up 4% - Here's What HappenedDecember 17, 2024 | marketbeat.comPfizer’s 2025 guidance positions company for EPS expansion, says BMODecember 17, 2024 | tipranks.comPfizer (NYSE:PFE) Shares Gap Up - Still a Buy?Pfizer (NYSE:PFE) Shares Gap Up - What's Next?December 17, 2024 | marketbeat.comStock Of The Day: Is Pfizer About To Break Out? Expect A New Uptrend If Resistance BreaksDecember 17, 2024 | benzinga.comPfizer Sees 2025 Revenue in Line With Wall Street ViewsDecember 17, 2024 | wsj.comPfizer provides FY25 outlook, McCormick in talks for Sauer Brands: Morning BuzzDecember 17, 2024 | tipranks.comPfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript)December 17, 2024 | seekingalpha.comPfizer Stock Rises as 2025 Outlook in Line With ExpectationsDecember 17, 2024 | investopedia.comPfizer (NYSE:PFE) Surges as FY25 Forecast Aligns with Wall StreetDecember 17, 2024 | tipranks.comPfizer Does Not Anticipate Material Changes To US Vaccine Policy From The Incoming Administration In 2025December 17, 2024 | benzinga.comPfizer ticks up as expectation-matching guidance relieves investorsDecember 17, 2024 | proactiveinvestors.comIs Pfizer Inc. (PFE) the Best Weight Loss Stock to Buy Now According to Hedge Funds?December 17, 2024 | insidermonkey.comPfizer (NYSE:PFE) Updates FY25 Earnings GuidancePfizer (NYSE:PFE) updated its FY25 earnings guidance. The company provided EPS guidance of $2.80-3.00 for the period, compared to the consensus estimate of $2.86. The company also issued revenue guidance of $61-64 billionillion, compared to the consensus estimate of $63.22 billionillion.December 17, 2024 | marketbeat.comPfizer (NYSE:PFE) Issues FY24 Earnings GuidancePfizer (NYSE:PFE) updated its FY24 earnings guidance. The company provided EPS guidance of $2.75-2.95 for the period, compared to the consensus estimate of $2.91. The company also issued revenue guidance of $61-64 billionillion, compared to the consensus estimate of $62.89 billionillion.December 17, 2024 | marketbeat.comPfizer (NYSE:PFE) Releases FY 2025 Earnings GuidancePfizer (NYSE:PFE) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.800-3.000 for the period, compared to the consensus estimate of 2.880. The company also issued revenue guidance of $61.0 billionillion-$64.0 billionillion, compared to the consensus estimate of $63.3 billionillion.December 17, 2024 | marketbeat.comPfizer issues 2025 outlook, reiterates 2024 guidanceDecember 17, 2024 | seekingalpha.comPfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 BillionDecember 17, 2024 | barrons.com Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin PFE Media Mentions By Week PFE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFE News Sentiment▼0.440.59▲Average Medical News Sentiment PFE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFE Articles This Week▼7040▲PFE Articles Average Week Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News AbbVie News Merck & Co., Inc. News Bristol-Myers Squibb News Zoetis News Royalty Pharma News Jazz Pharmaceuticals News Corcept Therapeutics News Perrigo News Supernus Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PFE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pfizer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PFE Stock Alerts